InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（7 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
7
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Brittenham Marissa, Directrice de la Stratégie. Insider active across 1 company, notably Surgery Partners, Inc.. In total, 12 disclosures have been logged. Breakdown: 0 buy · 7 sells. Total volume traded: €703k. History available since 1 February 2022. The latest transaction was filed on 13 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Brittenham Marissa
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
3,657 股@ US$12.542.5% 占其流量Common StockSEC:0001638833-26-000033:0
8,785 股@ US$13.706.2% 占其流量Common StockSEC:0001638833-26-000019:0
3,156 股@ US$24.093.6% 占其流量Common StockSEC:0001638833-25-000066:0
10,084 股@ US$23.8011.7% 占其流量Common StockSEC:0001638833-25-000047:0
14,700 股@ US$25.6118.6% 占其流量Common StockSEC:0001638833-25-000026:0
25,110 股0Common StockSEC:0001638833-25-000013:0
1,284 股@ US$30.171.8% 占其流量Common StockSEC:0001638833-24-000058:0
2,886 股@ US$31.184.3% 占其流量Common StockSEC:0001638833-24-000044:0
1,637 股@ US$31.892.5% 占其流量Common StockSEC:0001638833-24-000010:0
7,608 股@ US$32.8612.0% 占其流量Common StockSEC:0001638833-23-000034:0
1,320 股@ US$35.902.2% 占其流量Common StockSEC:0001638833-23-000006:0
10,602 股@ US$44.8025.3% 占其流量Common StockSEC:0001638833-22-000014:0
12 条申报中的 12 条
About Brittenham Marissa
Marissa Brittenham is Directrice de la Stratégie and Chief Strategy Officer at Surgery Partners, Inc. She has 12 filings in total, and across the recent sample of 12 filings, sells total EUR 702735, with activity from 2022-02-03 to 2026-03-16. The modal transaction nature is Cession.
